SVARLA
DEAD

Serial Number

79339423

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SVARLA Trademark

Serial Number: 79339423 • Registration: 6882149

SVARLA is a trademark filed by NOVARTIS AG on March 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 10, 2022

Registration Date

October 25, 2022

Published for Opposition

August 9, 2022

Cancellation Date

October 2, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 8, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 8, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 14, 2023 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 18, 2023 FICS
FINAL DISPOSITION PROCESSED
Feb 17, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 25, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 25, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 25, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 9, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 9, 2022 PUBO
REFUSAL PROCESSED BY IB
Aug 8, 2022 RFNT
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 20, 2022 NONP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 13, 2022 RFRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 7, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 7, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 7, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 7, 2022 CNEA
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 7, 2022 RFCR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 6, 2022 GPRN
PRIORITY ACTION E-MAILED
Jul 6, 2022 GPRA
PRIORITY ACTION WRITTEN
Jul 6, 2022 CPRA
ASSIGNED TO EXAMINER
Jul 5, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 20, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 20, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 20, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 20, 2022 COAR
APPLICATION FILING RECEIPT MAILED
May 17, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 10, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 28, 2022 SDRC